375 related articles for article (PubMed ID: 17631177)
21. 5-azacitidine: An alternative treatment of myelodysplastic syndromes in patient with refractory response to hematopoietic growth factor, a case report and review of literatures.
Suwanawiboon B; Sumida KN
Hawaii Med J; 2004 Jan; 63(1):14-6, 25. PubMed ID: 15011897
[TBL] [Abstract][Full Text] [Related]
22. Haemopoietic growth factors in myelodysplastic syndromes: towards patient-oriented therapy?
Clavio M; Balleari E; Garrone A; Ballerini F; Varaldo R; Michelis GL; Balocco M; Abdall N; Colombo N; Grasso R; Gobbi M
J Exp Clin Cancer Res; 2005 Mar; 24(1):5-16. PubMed ID: 15943026
[TBL] [Abstract][Full Text] [Related]
23. The hematopoietic growth factors in acute leukemia: a European perspective.
Heuser M; Ganser A; Hoelzer D
Cancer Treat Res; 2011; 157():339-62. PubMed ID: 21052965
[TBL] [Abstract][Full Text] [Related]
24. Haematopoietic growth factors and their therapeutic use.
Wadhwa M; Thorpe R
Thromb Haemost; 2008 May; 99(5):863-73. PubMed ID: 18449415
[TBL] [Abstract][Full Text] [Related]
25. Hematopoietic growth factors as adjuncts to antiretroviral therapy.
Miles SA
AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1073-80. PubMed ID: 1380256
[TBL] [Abstract][Full Text] [Related]
26. [Clinical use of hematopoietic growth factors].
Krusius T
Duodecim; 1990; 106(7):547-9. PubMed ID: 1727024
[No Abstract] [Full Text] [Related]
27. Current and future use of hematopoietic growth factors in cancer medicine.
Mughal TI
Hematol Oncol; 2004 Sep; 22(3):121-34. PubMed ID: 15991222
[TBL] [Abstract][Full Text] [Related]
28. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
29. Current status of growth factors in the treatment of acute myeloid and lymphoblastic leukemia.
Ottmann OG; Bug G; Krauter J
Semin Hematol; 2007 Jul; 44(3):183-92. PubMed ID: 17631182
[TBL] [Abstract][Full Text] [Related]
30. The role of haematopoietic growth factors in the treatment of myelodysplastic syndromes.
Rossi Ferrini P; Santini V; Ciolli S; Grossi A; Leoni F; Rafanelli D; Vannucchi AM
Hematol Oncol; 1993; 11 Suppl 1():32-5. PubMed ID: 7683622
[No Abstract] [Full Text] [Related]
31. Diamond-Blackfan anemia: expansion of erythroid progenitors in vitro by IL-9, but exclusion of a significant pathogenetic role for the IL-9 gene and the hematopoietic gene cluster on chromosome 5q.
Dianzani I; Garelli E; Crescenzio N; Timeus F; Mori PG; Varotto S; Nobili B; Brandalise S; Olivieri NF; Gabutti V; Ramenghi U
Exp Hematol; 1997 Nov; 25(12):1270-7. PubMed ID: 9357971
[TBL] [Abstract][Full Text] [Related]
32. [Hematopoietic growth factors in the treatment of acute myeloblastic leukemia].
de la Rubia Comos J
Sangre (Barc); 1997 Apr; 42 Suppl 1():32-3. PubMed ID: 9381298
[No Abstract] [Full Text] [Related]
33. Detection and quantification of functionally defined hematopoietic progenitor cells and tissue specific mRNA within the peripheral blood of myeloma patients after administration of granulocyte colony-stimulating factor and erythropoietin.
Grassinger J; Mueller G; Hart C; Nilsson SK; Haylock DN; Andreesen R; Hennemann B
Eur J Haematol; 2008 Jan; 80(1):20-30. PubMed ID: 18028434
[TBL] [Abstract][Full Text] [Related]
34. Hematopoietic growth factors in oncology.
Mertelsmann R; Lindemann A; Oster W; Gamm H; Kolbe K; Herrmann F
Cancer Detect Prev; 1990; 14(6):613-6. PubMed ID: 2257558
[TBL] [Abstract][Full Text] [Related]
35. Lineage-specific hematopoietic growth factors.
Kaushansky K
N Engl J Med; 2006 May; 354(19):2034-45. PubMed ID: 16687716
[No Abstract] [Full Text] [Related]
36. Potential use of human stem cell factor as adjunctive therapy for human immunodeficiency virus-related cytopenias.
Miles SA; Lee K; Hutlin L; Zsebo KM; Mitsuyasu RT
Blood; 1991 Dec; 78(12):3200-8. PubMed ID: 1720698
[TBL] [Abstract][Full Text] [Related]
37. [Use of hematopoietic growth factors].
Elonen E
Duodecim; 1995; 111(8):733-40. PubMed ID: 8681833
[No Abstract] [Full Text] [Related]
38. Future directions with hematopoietic growth factors.
Vadhan-Raj S
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S96-101. PubMed ID: 19795582
[TBL] [Abstract][Full Text] [Related]
39. [Hematopoietic growth factors: past, present, future].
Blay JY
Bull Cancer; 2006 May; 93(5):429. PubMed ID: 16777619
[No Abstract] [Full Text] [Related]
40. [Continuous treatment with colony stimulating factors (G-CSF) for neutropenia associated with type Ib glycogenosis].
de Diego Fernández P; García Fernández JR; Moreno Madrid F; Sánchez Forte M
An Esp Pediatr; 2001 Sep; 55(3):282-4. PubMed ID: 11676908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
